Home » Topics » BioWorld Science

BioWorld Science
RSS

SOV-2012-F1, oral testosterone formulation that improves patient satisfaction scores

March 23, 2021

New anti-CD19 antibodies presented by Viela Bio

March 23, 2021

Updated results from ongoing phase I/II MATINS study of bexmarilimab

March 23, 2021

Headless hemagglutinin makes for broad-spectrum flu vaccine

March 23, 2021

Incyte synthesizes adenosine A2A and/or A2B receptor antagonists

March 23, 2021

Terns identifies thyroid hormone receptor beta agonists

March 23, 2021

Roche discloses HBeAg and HBsAg secretion inhibitors

March 23, 2021

CaaMTech patents new ammonium tryptamines for pain

March 23, 2021

GRAd-COV2 vaccine candidate enters phase II/III development

March 23, 2021

Evotec and Takeda enter multi-RNA target alliance

March 23, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...